Lower stress and improve research insights with improvisational comedy
Quirks Media, Apr 25, 2017
Healthcare industry, or consumer health industry?
Healthcare IT News, Feb 13, 2017
Our industry is diligently working to understand and address the evolution of the healthcare consumer. However, it is still a reactive response. Instead, we need to proactively and strategically prepare for and manage the evolution.
Trump's Plan for Lowering Big Pharma Drug Prices Comes at a High Cost
Newsweek, Feb 3, 2017
On the last day in January, President Donald Trump met with chief executives from some of the wealthiest pharmaceutical companies in the United States to discuss the future of their industry. The Oval Office meeting, which was closed to the press after opening remarks, included an issue vital to most people not inside the room: the high price of pharmaceuticals.
Sales of Keytruda miss analysts' mark
MM&M, Feb 2, 2017
Sales of Merck's immunotherapy Keytruda slightly missed analysts' mark for the last three months of 2016, with U.S. sales coming in at $271 million, while consensus estimates were $296 million. Merck initially reported Keytruda sales of $311 million, but that figure included $40 million in deferred revenue.
Opdivo Making Strides in Advanced Hepatocellular Carcinoma
Oncology Business Review, Jan 23, 2017
It is an exciting time for patients and their doctors fighting advanced hepatocellular carcinoma (HCC).
Opdivo Shows Appetite for Gastric Cancer
Oncology Business Review, Jan 20, 2017
Before Cyramza® (ramucirumab, Eli Lilly and Co) was approved by the U.S. Food and Drug Administration (FDA) in 2014, no targeted therapy regimens were approved for use in relapsed/refractory gastric cancer.
White January: Keep an eye on your mental health
Kantar Brazil Insights, Jan 16, 2017
Mental disorders such as depression reach 16% of Brazilians.
How To Help Keep The Men In Your Life Healthy
Essence, Jan 13, 2017
Women are juggling a lot: running households, developing careers, managing finances, nurturing relationships and finding time for ourselves. Fifty-nine percent of us are also behind the wheel of our family's health care.
Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for Seciera™ for Treatment of Dry Eye
PipelineReview.com, Jan 4, 2017
Sun Pharma announced successful Phase 3 confirmatory clinical trial results for Seciera™ (cyclosporine A, 0.09% ophthalmic solution), for the treatment of dry eye disease.
Innovators 2016: Products
PM360, Dec 21, 2016
CancerLandscape aggregates many large oncology datasets, allowing for quick navigation of the data to better understand oncology drug opportunities and the competitive landscape.